Lessons from rare tumors: Hepatic lymphoepithelioma-like carcinomas

World Journal of Gastroenterology

Volumn 21, Issue 12, 2015, Pages 3472-3479

  Solinas, Antonio ^a   Calvisi, Diego F ^a,b  

^a UNIVERSITY OF SASSARI   (Italy)

^b UNIVERSITY OF GREIFSWALD   (Germany)

Author keywords

Epstein Barr virus infection; Lymphoepithelioma; Lymphoepithelioma like carcinoma; Lymphoepithelioma like intrahepatic cholangiocarcinoma; Lymphoepitheliomalike hepatocellular carcinoma; Nasopharyngeal carcinoma

Indexed keywords

BILE DUCT CARCINOMA; CANCER CELL; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL FEATURE; DISEASE SEVERITY; EPSTEIN BARR VIRUS INFECTION; HEPATITIS C; HUMAN; IMMUNE SYSTEM; LIVER CELL CARCINOMA; LYMPHOCYTIC INFILTRATION; LYMPHOEPITHELIOMA; LYMPHOEPITHELIOMA LIKE HEPATOCELLULAR CARCINOMA; NASOPHARYNX CARCINOMA; OVERALL SURVIVAL; RARE DISEASE; REVIEW; TUMOR MICROENVIRONMENT; CARCINOMA; CHOLANGIOCARCINOMA; COMPLICATION; IMMUNOLOGY; LIVER NEOPLASMS; LYMPHOMA; MORTALITY; PATHOLOGY; RISK FACTOR; TREATMENT OUTCOME; VIROLOGY;

CARCINOMA; CHOLANGIOCARCINOMA; EPSTEIN-BARR VIRUS INFECTIONS; HEPATITIS C; HUMANS; LIVER NEOPLASMS; LYMPHOMA; RISK FACTORS; TREATMENT OUTCOME;

EID: 84926335949     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v21.i12.3472     Document Type: Review

References (101)

1. Fee WE. Nasopharyngeal carcinoma. Curr Opin Oncol 1990; 2: 585-588 [PMID: 2092778 DOI: 10.1097/00001622-199006000-00024]
2. Klein G, Giovanella BC, Lindahl T, Fialkow PJ, Singh S, Stehlin JS. Direct evidence for the presence of Epstein-Barr virus DNA and nuclear antigen in malignant epithelial cells from patients with poorly differentiated carcinoma of the nasopharynx. Proc Natl Acad Sci USA 1974; 71: 4737-4741 [PMID: 4373728 DOI: 10.1073/pnas.71.12.4737]
3. Yoshizaki T, Kondo S, Wakisaka N, Murono S, Endo K, Sugimoto H, Nakanishi S, Tsuji A, Ito M. Pathogenic role of Epstein-Barr virus latent membrane protein-1 in the development of nasopharyngeal carcinoma. Cancer Lett 2013; 337: 1-7 [PMID: 23689138 DOI: 10.1016/j.canlet.2013.05.018]
4. Chien YC, Chen JY, Liu MY, Yang HI, Hsu MM, Chen CJ, Yang CS. Serologic markers of Epstein-Barr virus infection and nasopharyngeal carcinoma in Taiwanese men. N Engl J Med 2001; 345: 1877-1882 [PMID: 11756578 DOI: 10.1056/NEJMoa011610]
5. Ma H, Lin Y, Wang L, Rao H, Xu G, He Y, Liang Y. Primary lymphoepithelioma-like carcinoma of salivary gland: sixty-nine cases with long-term follow-up. Head Neck 2014; 36: 1305-1312 [PMID: 23966284 DOI: 10.1002/hed.23450]
6. Huang YC, Hsueh C, Ho SY, Liao CY. Lymphoepithelioma-like carcinoma of the lung: an unusual case and literature review. Case Rep Pulmonol 2013; 2013: 143405 [PMID: 24288644 DOI: 10.1155/2013/143405]
7. Chen PC, Pan CC, Yang AH, Wang LS, Chiang H. Detection of Epstein-Barr virus genome within thymic epithelial tumours in Taiwanese patients by nested PCR, PCR in situ hybridization, and RNA in situ hybridization. J Pathol 2002; 197: 684-688 [PMID: 12210090 DOI: 10.1002/path.1141]
8. Bittar Z, Fend F, Quintanilla-Martinez L. Lymphoepithelioma-like carcinoma of the stomach: a case report and review of the literature. Diagn Pathol 2013; 8: 184 [PMID: 24188515 DOI: 10.1186/1746-1596-8-184]
9. Samaha S, Tawfik O, Horvat R, Bhatia P. Lymphoepithelioma-like carcinoma of the colon: report of a case with histologic, immunohistochemical, and molecular studies for Epstein-Barr virus. Dis Colon Rectum 1998; 41: 925-928 [PMID: 9678381 DOI: 10.1007/BF02235379]
10. Mori T, Sawada M, Matsuo S, Kuroboshi H, Tatsumi H, Iwasaku K, Kitawaki J. Lymphoepithelial-like carcinoma of the uterine cervix; a case report. Eur J Gynaecol Oncol 2011; 32: 325-327 [PMID: 21797126]
11. Lee S, Park SY, Hong EK, Ro JY. Lymphoepithelioma-like carcinoma of the ovary: a case report and review of the literature. Arch Pathol Lab Med 2007; 131: 1715-1718 [PMID: 17979492]
12. Mori K, Ando T, Nomura T, Sato F, Mimata H. Lymphoepithelioma-like carcinoma of the bladder: a case report and review of the literature. Case Rep Urol 2013; 2013: 356576 [PMID: 23710410 DOI: 10.1155/2013/356576]
13. Dinniwell R, Hanna WM, Mashhour M, Saad RS, Czarnota GJ. Lymphoepithelioma-like carcinoma of the breast: a diagnostic and therapeutic challenge. Curr Oncol 2012; 19: e177-e183 [PMID: 22670107 DOI: 10.3747/co.19.926]
14. López V, Martín JM, Santonja N, Molina I, Ramón D, Monteagudo C, Jordá E. Lymphoepitelioma-like carcinoma of the skin: report of three cases. J Cutan Pathol 2011; 38: 54-58 [PMID: 19922479 DOI: 10.1111/j.1600-0560.2009.01458.x]
15. Lee JY, Kim KM, Min BH, Lee JH, Rhee PL, Kim JJ. Epstein- Barr virus-associated lymphoepithelioma-like early gastric carcinomas and endoscopic submucosal dissection: case series. World J Gastroenterol 2014; 20: 1365-1370 [PMID: 24574813 DOI: 10.3748/wjg.v20.i5.1365]
16. Pittaluga S, Wong MP, Chung LP, Loke SL. Clonal Epstein-Barr virus in lymphoepithelioma-like carcinoma of the lung. Am J Surg Pathol 1993; 17: 678-682 [PMID: 8391220 DOI: 10.1097/000004 78-199307000-00004]
17. Gómez-Román JJ, Martínez MN, Fernández SL, Val-Bernal JF. Epstein-Barr virus-associated adenocarcinomas and squamous-cell lung carcinomas. Mod Pathol 2009; 22: 530-537 [PMID: 19252476 DOI: 10.1038/modpathol.2009.7]
18. Koppula BR, Pipavath S, Lewis DH. Epstein-Barr virus (EBV) associated lymphoepithelioma-like thymic carcinoma associated with paraneoplastic syndrome of polymyositis: a rare tumor with rare association. Clin Nucl Med 2009; 34: 686-688 [PMID: 19893401 DOI: 10.1097/RLU.0b013e3181b53f5a]
19. Nio Y, Tsuboi K, Tamaoki M, Tamaoki M, Maruyama R. Lymphoepithelioma-like carcinoma of the breast: a case report with a special analysis of an association with human papilloma virus. Anticancer Res 2012; 32: 1435-1441 [PMID: 22493382]
20. Noel J, Lespagnard L, Fayt I, Verhest A, Dargent J. Evidence of human papilloma virus infection but lack of Epstein-Barr virus in lymphoepithelioma-like carcinoma of uterine cervix: report of two cases and review of the literature. Hum Pathol 2001; 32: 135-138 [PMID: 11172309]
21. Wada Y, Nakashima O, Kutami R, Yamamoto O, Kojiro M. Clinicopathological study on hepatocellular carcinoma with lymphocytic infiltration. Hepatology 1998; 27: 407-414 [PMID: 9462638 DOI: 10.1002/hep.510270214]
22. Emile JF, Adam R, Sebagh M, Marchadier E, Falissard B, Dussaix E, Bismuth H, Reynès M. Hepatocellular carcinoma with lymphoid stroma: a tumour with good prognosis after liver transplantation. Histopathology 2000; 37: 523-529 [PMID: 11122434 DOI: 10.1046/j.1365-2559.2000.00952.x]
23. Patel KR, Liu TC, Vaccharajani N, Chapman WC, Brunt EM. Characterization of inflammatory (lymphoepithelioma-like) hepatocellular carcinoma: a study of 8 cases. Arch Pathol Lab Med 2014; 138: 1193-1202 [PMID: 25171701 DOI: 10.5858/arpa.2013-0371-OA]
24. Shinoda M, Kadota Y, Tsujikawa H, Masugi Y, Itano O, Ueno A, Mihara K, Hibi T, Abe Y, Yagi H, Kitago M, Kawachi S, Tanimoto A, Sakamoto M, Tanabe M, Kitagawa Y. Lymphoepithelioma-like hepatocellular carcinoma: a case report and a review of the literature. World J Surg Oncol 2013; 11: 97 [PMID: 23642182 DOI: 10.1186/1477-7819-11-97]
25. Park HS, Jang KY, Kim YK, Cho BH, Moon WS. Hepatocellular carcinoma with massive lymphoid infiltration: a regressing phenomenon? Pathol Res Pract 2009; 205: 648-652 [PMID: 19217218 DOI: 10.1016/j.prp.2009.01.001]
26. Szekely E. Hepatocellular carcinoma with lymphoid stroma: 'lymphoepithelioma-like carcinoma'? Histopathology 2001; 39: 540 [PMID: 11737314 DOI: 10.1046/j.1365-2559.2001.1301a.x]
27. Si MW, Thorson JA, Lauwers GY, DalCin P, Furman J. Hepatocellular lymphoepithelioma-like carcinoma associated with epstein barr virus: a hitherto unrecognized entity. Diagn Mol Pathol 2004; 13: 183-189 [PMID: 15322431 DOI: 10.1097/01.pas.0000124336.90615.8d]
28. Chen CJ, Jeng LB, Huang SF. Lymphoepithelioma-like hepatocellular carcinoma. Chang Gung Med J 2007; 30: 172-177 [PMID: 17596007]
29. Nemolato S, Fanni D, Naccarato AG, Ravarino A, Bevilacqua G, Faa G. Lymphoepitelioma-like hepatocellular carcinoma: a case report and a review of the literature. World J Gastroenterol 2008; 14: 4694-4696 [PMID: 18698686 DOI: 10.3748/wjg.14.4694]
30. Chan AW, Tong JH, Sung MY, Lai PB, To KF. Epstein-Barr virus-associated lymphoepithelioma-like cholangiocarcinoma: a rare variant of intrahepatic cholangiocarcinoma with favourable outcome. Histopathology 2014; 65: 674-683 [PMID: 24804938 DOI: 10.1111/his.12455]
31. Jeng YM, Chen CL, Hsu HC. Lymphoepithelioma-like cholangiocarcinoma: an Epstein-Barr virus-associated tumor. Am J Surg Pathol 2001; 25: 516-520 [PMID: 11257627]
32. Hsu HC, Chen CC, Huang GT, Lee PH. Clonal Epstein-Barr virus associated cholangiocarcinoma with lymphoepithelioma-like component. Hum Pathol 1996; 27: 848-850 [PMID: 8760021 DOI: 10.1097/00000478-200104000-00012]
33. Vortmeyer AO, Kingma DW, Fenton RG, Curti BD, Jaffe ES, Duray PH. Hepatobiliary lymphoepithelioma-like carcinoma associated with Epstein-Barr virus. Am J Clin Pathol 1998; 109: 90-95 [PMID: 9426523 DOI: 10.1016/S0046-8177(96)90460-8]
34. Ortiz MR, Garijo G, Adrados M, López-Bonet E, Acero D, Bernadó L. Epstein-Barr Virus-Associated Cholangiocarcinoma with Lymphoepithelioma-Like Component. Int J Surg Pathol 2000; 8: 347-351 [PMID: 11494016 DOI: 10.1177/106689690000800418]
35. Chen TC, Ng KF, Kuo T. Intrahepatic cholangiocarcinoma with lymphoepithelioma-like component. Mod Pathol 2001; 14: 527-532 [PMID: 11353065 DOI: 10.1038/modpathol.3880342]
36. Huang Y, Tsung JS, Lin CW, Cheng TY. Intrahepatic cholangiocarcinoma with lymphoepithelioma-like carcinoma component. Ann Clin Lab Sci 2004; 34: 476-480 [PMID: 15648792]
37. Henderson-Jackson E, Nasir NA, Hakam A, Nasir A, Coppola D. Primary mixed lymphoepithelioma-like carcinoma and intra-hepatic cholangiocarcinoma: a case report and review of literature. Int J Clin Exp Pathol 2010; 3: 736-741 [PMID: 20830246]
38. Kim YB, Park YN, Han JY, Hong KC, Hwang TS. Biliary lymphoepithelioma-like carcinoma not associated with Epstein-Barr virus. Arch Pathol Lab Med 1999; 123: 441-443 [PMID: 10235506]
39. Szekely E. Lymphoepithelioma-like cholangiocarcinoma (LELC) not associated with Epstein-Barr virus. Am J Surg Pathol 2001; 25: 1464-1466 [PMID: 11684969 DOI: 10.1097/00000478-200111000-00023]
40. Adachi S, Morimoto O, Kobayashi T. Lymphoepithelioma-like cholangiocarcinoma not associated with EBV. Pathol Int 2008; 58: 69-74 [PMID: 18067645 DOI: 10.1111/j.1440-1827.2007.02192.x]
41. Lee W. Intrahepatic lymphoepithelioma-like cholangiocarcinoma not associated with epstein-barr virus: a case report. Case Rep Oncol 2011; 4: 68-73 [PMID: 21475593 DOI: 10.1159/000324485]
42. Hur YH, Kim HH, Koh YS, Seoung JS, Cho CK. Lymphoepithelioma-like cholangiocarcinoma not associated with Epstein-Barr virus. ANZ J Surg 2011; 81: 652-653 [PMID: 22295412 DOI: 10.1111/j.1445-2197.2011.05840.x]
43. Bosman FT, Carneiro F, Hruban RH, Theise ND, editors. Classification of Tumours. 3rd ed. Lyon, France: IARC Press, 2010
44. Yang XH, Yamagiwa S, Ichida T, Matsuda Y, Sugahara S, Watanabe H, Sato Y, Abo T, Horwitz DA, Aoyagi Y. Increase of CD4+ CD25+ regulatory T-cells in the liver of patients with hepatocellular carcinoma. J Hepatol 2006; 45: 254-262 [PMID: 16600416 DOI: 10.1016/j.jhep.2006.01.036]
45. Sprinzl MF, Galle PR. Immune control in hepatocellular carcinoma development and progression: role of stromal cells. Semin Liver Dis 2014; 34: 376-388 [PMID: 25369300 DOI: 10.1055/s-0034-1394138]
46. Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow? Lancet 2001; 357: 539-545 [PMID: 11229684 DOI: 10.1016/S0140-6736(00)04046-0]
47. Balkwill FR. The chemokine system and cancer. J Pathol 2012; 226: 148-157 [PMID: 21989643]
48. Ba lkwi l l FR, Ca p a s s o M, Ha g ema n n T. Th e t umo r microenvironment at a glance. J Cell Sci 2012; 125: 5591-5596 [PMID: 23420197 DOI: 10.1242/jcs.116392]
49. Galdiero MR, Bonavita E, Barajon I, Garlanda C, Mantovani A, Jaillon S. Tumor associated macrophages and neutrophils in cancer. Immunobiology 2013; 218: 1402-1410 [PMID: 23891329 DOI: 10.1016/j.imbio.2013.06.003]
50. Kulbe H, Chakravarty P, Leinster DA, Charles KA, Kwong J, Thompson RG, Coward JI, Schioppa T, Robinson SC, Gallagher WM, Galletta L, Salako MA, Smyth JF, Hagemann T, Brennan DJ, Bowtell DD, Balkwill FR. A dynamic inflammatory cytokine network in the human ovarian cancer microenvironment. Cancer Res 2012; 72: 66-75 [PMID: 22065722 DOI: 10.1158/0008-5472.CAN-11-2178]
51. Huang F, Geng XP. Chemokines and hepatocellular carcinoma. World J Gastroenterol 2010; 16: 1832-1836 [PMID: 20397259 DOI: 10.3748/wjg.v16.i15.1832]
52. Yoong KF, Afford SC, Jones R, Aujla P, Qin S, Price K, Hubscher SG, Adams DH. Expression and function of CXC and CC chemokines in human malignant liver tumors: a role for human monokine induced by gamma-interferon in lymphocyte recruitment to hepatocellular carcinoma. Hepatology 1999; 30: 100-111 [PMID: 10385645 DOI: 10.1002/hep.510300147]
53. Fujii H, Itoh Y, Yamaguchi K, Yamauchi N, Harano Y, Nakajima T, Minami M, Okanoue T. Chemokine CCL20 enhances the growth of HuH7 cells via phosphorylation of p44/42 MAPK in vitro. Biochem Biophys Res Commun 2004; 322: 1052-1058 [PMID: 15336571 DOI: 10.1016/j.bbrc.2004.07.207]
54. Sutton A, Friand V, Brulé-Donneger S, Chaigneau T, Ziol M, Sainte-Catherine O, Poiré A, Saffar L, Kraemer M, Vassy J, Nahon P, Salzmann JL, Gattegno L, Charnaux N. Stromal cell-derived factor-1/chemokine (C-X-C motif) ligand 12 stimulates human hepatoma cell growth, migration, and invasion. Mol Cancer Res 2007; 5: 21-33 [PMID: 17259344 DOI: 10.1158/1541-7786.MCR-06-0103]
55. Ghanem I, Riveiro ME, Paradis V, Faivre S, de Parga PM, Raymond E. Insights on the CXCL12-CXCR4 axis in hepatocellular carcinoma carcinogenesis. Am J Transl Res 2014; 6: 340-352 [PMID: 25075251]
56. Ren Y, Poon RT, Tsui HT, Chen WH, Li Z, Lau C, Yu WC, Fan ST. Interleukin-8 serum levels in patients with hepatocellular carcinoma: correlations with clinicopathological features and prognosis. Clin Cancer Res 2003; 9: 5996-6001 [PMID: 14676125]
57. Yuan Y, Liu J, Liu Z, He Y, Zhang Z, Jiang C, Qian Q. Chemokine CCL3 facilitates the migration of hepatoma cells by changing the concentration intracellular Ca. Hepatol Res 2010; 40: 424-431 [PMID: 20236357 DOI: 10.1111/j.1872-034X.2009.00619.x]
58. Du D, Liu Y, Qian H, Zhang B, Tang X, Zhang T, Liu W. The effects of the CCR6/CCL20 biological axis on the invasion and metastasis of hepatocellular carcinoma. Int J Mol Sci 2014; 15: 6441-6452 [PMID: 24743888 DOI: 10.3390/ijms15046441]
59. Yang P, Li QJ, Feng Y, Zhang Y, Markowitz GJ, Ning S, Deng Y, Zhao J, Jiang S, Yuan Y, Wang HY, Cheng SQ, Xie D, Wang XF. TGF-β-miR-34a-CCL22 signaling-induced Treg cell recruitment promotes venous metastases of HBV-positive hepatocellular carcinoma. Cancer Cell 2012; 22: 291-303 [PMID: 22975373]
60. Pagès F, Galon J, Dieu-Nosjean MC, Tartour E, Sautès-Fridman C, Fridman WH. Immune infiltration in human tumors: a prognostic factor that should not be ignored. Oncogene 2010; 29: 1093-1102 [PMID: 19946335]
61. Chew V, Tow C, Teo M, Wong HL, Chan J, Gehring A, Loh M, Bolze A, Quek R, Lee VK, Lee KH, Abastado JP, Toh HC, Nardin A. Inflammatory tumour microenvironment is associated with superior survival in hepatocellular carcinoma patients. J Hepatol 2010; 52: 370-379 [PMID: 19720422 DOI: 10.1016/j.jhep.2009.07.013]
62. Chew V, Chen J, Lee D, Loh E, Lee J, Lim KH, Weber A, Slankamenac K, Poon RT, Yang H, Ooi LL, Toh HC, Heikenwalder M, Ng IO, Nardin A, Abastado JP. Chemokine-driven lymphocyte infiltration: an early intratumoural event determining long-term survival in resectable hepatocellular carcinoma. Gut 2012; 61: 427-438 [PMID: 21930732 DOI: 10.1136/gutjnl-2011-300509]
63. Tacke F, Zimmermann HW, Berres ML, Trautwein C, Wasmuth HE. Serum chemokine receptor CXCR3 ligands are associated with progression, organ dysfunction and complications of chronic liver diseases. Liver Int 2011; 31: 840-849 [PMID: 21645215 DOI: 10.1111/j.1478-3231.2011.02504.x]
64. Romero AI, Lagging M, Westin J, Dhillon AP, Dustin LB, Pawlotsky JM, Neumann AU, Ferrari C, Missale G, Haagmans BL, Schalm SW, Zeuzem S, Negro F, Verheij-Hart E, Hellstrand K. Interferon (IFN)-gamma-inducible protein-10: association with histological results, viral kinetics, and outcome during treatment with pegylated IFN-alpha 2a and ribavirin for chronic hepatitis C virus infection. J Infect Dis 2006; 194: 895-903 [PMID: 16960776 DOI: 10.1086/507307]
65. Zeremski M, Petrovic LM, Chiriboga L, Brown QB, Yee HT, Kinkhabwala M, Jacobson IM, Dimova R, Markatou M, Talal AH. Intrahepatic levels of CXCR3-associated chemokines correlate with liver inflammation and fibrosis in chronic hepatitis C. Hepatology 2008; 48: 1440-1450 [PMID: 18798334 DOI: 10.1002/hep.22500]
66. Marra F, Tacke F. Roles for chemokines in liver disease. Gastroenterology 2014; 147: 577-594.e1 [PMID: 25066692 DOI: 10.1053/j.gastro.2014.06.043]
67. Hsu JL, Glaser SL. Epstein-barr virus-associated malignancies: epidemiologic patterns and etiologic implications. Crit Rev Oncol Hematol 2000; 34: 27-53 [PMID: 10781747 DOI: 10.1016/S1040-8428(00)00046-9]
68. Magrath I. Epidemiology: clues to the pathogenesis of Burkitt lymphoma. Br J Haematol 2012; 156: 744-756 [PMID: 22260300 DOI: 10.1111/j.1365-2141.2011.09013.x]
69. Vockerodt M, Yap LF, Shannon-Lowe C, Curley H, Wei W, Vrzalikova K, Murray PG. The Epstein-Barr virus and the pathogenesis of lymphoma. J Pathol 2015; 235: 312-322 [PMID: 25294567 DOI: 10.1002/path.4459]
70. Rouce RH, Louis CU, Heslop HE. Epstein-Barr virus lymphoproliferative disease after hematopoietic stem cell transplant. Curr Opin Hematol 2014; 21: 476-481 [PMID: 25159713 DOI: 10.1097/MOH.0000000000000083]
71. Salyakina D, Tsinoremas NF. Viral expression associated with gastrointestinal adenocarcinomas in TCGA high-throughput sequencing data. Hum Genomics 2013; 7: 23 [PMID: 24279398 DOI: 10.1186/1479-7364-7-23]
72. Tetzlaff MT, Nosek C, Kovarik CL. Epstein-Barr virus-associated leiomyosarcoma with cutaneous involvement in an African child with human immunodeficiency virus: a case report and review of the literature. J Cutan Pathol 2011; 38: 731-739 [PMID: 21623869 DOI: 10.1111/j.1600-0560.2011.01721.x]
73. Han BL, Xu XY, Zhang CZ, Wu JJ, Han CF, Wang H, Wang X, Wang GS, Yang SJ, Xie Y. Systematic review on Epstein-Barr virus (EBV) DNA in diagnosis of nasopharyngeal carcinoma in Asian populations. Asian Pac J Cancer Prev 2012; 13: 2577-2581 [PMID: 22938423]
74. Houldcroft CJ, Kellam P. Host genetics of Epstein-Barr virus infection, latency and disease. Rev Med Virol 2015; 25: 71-84 [PMID: 25430668 DOI: 10.1002/rmv.1816]
75. Coghill AE, Hildesheim A. Epstein-Barr virus antibodies and the risk of associated malignancies: review of the literature. Am J Epidemiol 2014; 180: 687-695 [PMID: 25167864 DOI: 10.1093/aje/kwu176]
76. Lo KW, Chung GT, To KF. Deciphering the molecular genetic basis of NPC through molecular, cytogenetic, and epigenetic approaches. Semin Cancer Biol 2012; 22: 79-86 [PMID: 22245473 DOI: 10.1016/j.semcancer.2011.12.011]
77. Lo KW, Teo PM, Hui AB, To KF, Tsang YS, Chan SY, Mak KF, Lee JC, Huang DP. High resolution allelotype of microdissected primary nasopharyngeal carcinoma. Cancer Res 2000; 60: 3348-3353 [PMID: 10910036]
78. Hui AB, Or YY, Takano H, Tsang RK, To KF, Guan XY, Sham JS, Hung KW, Lam CN, van Hasselt CA, Kuo WL, Gray JW, Huang DP, Lo KW. Array-based comparative genomic hybridization analysis identified cyclin D1 as a target oncogene at 11q13.3 in nasopharyngeal carcinoma. Cancer Res 2005; 65: 8125-8133 [PMID: 16166286 DOI: 10.1158/0008-5472.CAN-05-0648]
79. Or YY, Chung GT, To KF, Chow C, Choy KW, Tong CY, Leung AW, Hui AB, Tsao SW, Ng HK, Yip TT, Busson P, Lo KW. Identification of a novel 12p13.3 amplicon in nasopharyngeal carcinoma. J Pathol 2010; 220: 97-107 [PMID: 19718711 DOI: 10.1002/path.2609]
80. Lu QL, Elia G, Lucas S, Thomas JA. Bcl-2 proto-oncogene expression in Epstein-Barr-virus-associated nasopharyngeal carcinoma. Int J Cancer 1993; 53: 29-35 [PMID: 8380056 DOI: 10.1002/ijc.2910530107]
81. Catalogue of Somatic Mutations In Cancer (COSMIC). Available from: URL: http://www.cancer.sanger.ac.uk/cosmic
82. Gourzones C, Barjon C, Busson P. Host-tumor interactions in nasopharyngeal carcinomas. Semin Cancer Biol 2012; 22: 127-136 [PMID: 22249142 DOI: 10.1016/j.semcancer.2012.01.002]
83. Herait P, Ganem G, Lipinski M, Carlu C, Micheau C, Schwaab G, De-The G, Tursz T. Lymphocyte subsets in tumour of patients with undifferentiated nasopharyngeal carcinoma: presence of lymphocytes with the phenotype of activated T cells. Br J Cancer 1987; 55: 135-139 [PMID: 3545275 DOI: 10.1038/bjc.1987.28]
84. Ferradini L, Miescher S, Stoeck M, Busson P, Barras C, Cerf-Bensussan N, Lipinski M, von Fliedner V, Tursz T. Cytotoxic potential despite impaired activation pathways in T lymphocytes infiltrating nasopharyngeal carcinoma. Int J Cancer 1991; 47: 362-370 [PMID: 1899651 DOI: 10.1002/ijc.2910470309]
85. Lau KM, Cheng SH, Lo KW, Lee SA, Woo JK, van Hasselt CA, Lee SP, Rickinson AB, Ng MH. Increase in circulating Foxp3+CD4+CD25(high) regulatory T cells in nasopharyngeal carcinoma patients. Br J Cancer 2007; 96: 617-622 [PMID: 17262084 DOI: 10.1038/sj.bjc.6603580]
86. Li J, Huang ZF, Xiong G, Mo HY, Qiu F, Mai HQ, Chen QY, He J, Chen SP, Zheng LM, Qian CN, Zeng YX. Distribution, characterization, and induction of CD8+ regulatory T cells and IL-17-producing CD8+ T cells in nasopharyngeal carcinoma. J Transl Med 2011; 9: 189 [PMID: 22051182 DOI: 10.1186/1479-5876-9-189]
87. Busson P, Braham K, Ganem G, Thomas F, Grausz D, Lipinski M, Wakasugi H, Tursz T. Epstein-Barr virus-containing epithelial cells from nasopharyngeal carcinoma produce interleukin 1 alpha. Proc Natl Acad Sci USA 1987; 84: 6262-6266 [PMID: 2819868 DOI: 10.1073/pnas.84.17.6262]
88. Hu H, Tang KF, Chua YN, Lu J, Feng P, Chew CT, Chan SH. Expression of interleukin-18 by nasopharyngeal carcinoma cells: a factor that possibly initiates the massive leukocyte infiltration. Hum Pathol 2004; 35: 722-728 [PMID: 15188138 DOI: 10.1016/j.humpath.2004.01.026]
89. Teichmann M, Meyer B, Beck A, Niedobitek G. Expression of the interferon-inducible chemokine IP-10 (CXCL10), a chemokine with proposed anti-neoplastic functions, in Hodgkin lymphoma and nasopharyngeal carcinoma. J Pathol 2005; 206: 68-75 [PMID: 15751051 DOI: 10.1002/path.1745]
90. Chang KP, Hao SP, Chang JH, Wu CC, Tsang NM, Lee YS, Hsu CL, Ueng SH, Liu SC, Liu YL, Wei PC, Liang Y, Chang YS, Yu JS. Macrophage inflammatory protein-3alpha is a novel serum marker for nasopharyngeal carcinoma detection and prediction of treatment outcomes. Clin Cancer Res 2008; 14: 6979-6987 [PMID: 18980993 DOI: 10.1158/1078-0432.CCR-08-0090]
91. Nanbo A, Takada K. The role of Epstein-Barr virus-encoded small RNAs (EBERs) in oncogenesis. Rev Med Virol 2002; 12: 321-326 [PMID: 12211044 DOI: 10.1002/rmv.363]
92. Murray RJ, Kurilla MG, Brooks JM, Thomas WA, Rowe M, Kieff E, Rickinson AB. Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV): implications for the immune control of EBV-positive malignancies. J Exp Med 1992; 176: 157-168 [PMID: 1319456 DOI: 10.1084/jem.176.1.157]
93. Sample J, Brooks L, Sample C, Young L, Rowe M, Gregory C, Rickinson A, Kieff E. Restricted Epstein-Barr virus protein expression in Burkitt lymphoma is due to a different Epstein-Barr nuclear antigen 1 transcriptional initiation site. Proc Natl Acad Sci USA 1991; 88: 6343-6347 [PMID: 1648738]
94. Lara J, Cohen M, De Matteo E, Aversa L, Preciado MV, Chabay P. Epstein-Barr virus (EBV) association and latency profile in pediatric Burkitt's lymphoma: experience of a single institution in Argentina. J Med Virol 2014; 86: 845-850 [PMID: 24027016 DOI: 10.1002/jmv.23737]
95. Rosales-Pérez S, Cano-Valdez AM, Flores-Balcázar CH, Guedea-Edo F, Lino-Silva LS, Lozano-Borbalas A, Navarro-Martín A, Poitevin-Chacón A. Expression of Epstein-Barr virus-encoded latent membrane protein (LMP-1), p16 and p53 proteins in nonendemic nasopharyngeal carcinoma (NPC): a clinicopathological study. Arch Med Res 2014; 45: 229-236 [PMID: 24606815 DOI: 10.1016/j.arcmed.2014.02.002]
96. Dawson CW, Port RJ, Young LS. The role of the EBV-encoded latent membrane proteins LMP1 and LMP2 in the pathogenesis of nasopharyngeal carcinoma (NPC). Semin Cancer Biol 2012; 22: 144-153 [PMID: 22249143 DOI: 10.1016/j.semcancer.2012.01.004]
97. Rochford R, Mosier DE. Differential Epstein-Barr virus gene expression in B-cell subsets recovered from lymphomas in SCID mice after transplantation of human peripheral blood lymphocytes. J Virol 1995; 69: 150-155 [PMID: 7983705]
98. Castillo JJ, Beltran BE, Miranda RN, Paydas S, Winer ES, Butera JN. Epstein-barr virus-positive diffuse large B-cell lymphoma of the elderly: what we know so far. Oncologist 2011; 16: 87-96 [PMID: 21212426 DOI: 10.1634/theoncologist.2010-0213]
99. Murata T. Regulation of Epstein-Barr virus reactivation from latency. Microbiol Immunol 2014; 58: 307-317 [PMID: 24786491 DOI: 10.1111/1348-0421.12155]
100. Lee JM, Kim H, Noh SH, Lee WY, Kim SJ, Park JH. Expression of Epstein-Barr Virus Gene and Clonality of Infiltrated T Lymphocytes in Epstein-Barr Virus-associated Gastric Carcinoma. Immune Netw 2011; 11: 50-58 [PMID: 21494374 DOI: 10.4110/in.2011.11.1.50]
101. Zhou SL, Dai Z, Zhou ZJ, Chen Q, Wang Z, Xiao YS, Hu ZQ, Huang XY, Yang GH, Shi YH, Qiu SJ, Fan J, Zhou J. CXCL5 contributes to tumor metastasis and recurrence of intrahepatic cholangiocarcinoma by recruiting infiltrative intratumoral neutrophils. Carcinogenesis 2014; 35: 597-605 [PMID: 24293410 DOI: 10.1093/carcin/bgt397]